to determine the efficacy of indomethacin to prevent the occurrence of symptomatic patent ductus arteriosus ( pda ) , a randomized clinical trial was conducted involving 32 preterm infants weighing 750 to 1500 g at birth who had hyaline membrane disease .
C0021246
indomethacin
C0013274
patent ductus arteriosus